EE200400010A - 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid - Google Patents

4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid

Info

Publication number: EE200400010A
Authority: EE; Estonia
Prior art keywords: hydroxydiphenylmethyl; hydroxybutyl; piperidinyl; hydrochloride; crystalline forms
Prior art date: 2001-06-18

Application number

EEP200400010A

Other languages

English (en)

Estonian (et)

Inventor

Satyanarayana Reddy M.

Thirumalai Rajan S.

V. Bhaskara Rao U.

Original Assignee

Dr. Reddy's Laboratories Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-18

Filing date

2001-07-31

Publication date

2004-02-16

2001-07-31 Application filed by Dr. Reddy's Laboratories Ltd. filed Critical Dr. Reddy's Laboratories Ltd.

2004-02-16 Publication of EE200400010A publication Critical patent/EE200400010A/xx

Links

VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP200400010A 2001-06-18 2001-07-31 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid EE200400010A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN484MA2001		2001-06-18
PCT/US2001/023994 WO2002102777A2 (fr)	2001-06-18	2001-07-31	Nouvelles formes cristallines d'acide 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a)-$g(a)- dimethylbenzene acetique et son chlorhydrate

Publications (1)

Publication Number	Publication Date
EE200400010A true EE200400010A (et)	2004-02-16

Family

ID=34566868

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200400010A EE200400010A (et)	2001-06-18	2001-07-31	4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid

Country Status (20)

Country	Link
EP (2)	EP2261209A1 (fr)
JP (2)	JP2005507374A (fr)
KR (1)	KR20040015734A (fr)
CN (1)	CN100390145C (fr)
AU (1)	AU2001278094B2 (fr)
BG (1)	BG108435A (fr)
BR (1)	BR0117054A (fr)
CA (2)	CA2450858C (fr)
CO (1)	CO5540340A2 (fr)
CZ (1)	CZ20033358A3 (fr)
EE (1)	EE200400010A (fr)
HU (1)	HUP0401546A2 (fr)
IL (2)	IL159266A0 (fr)
MX (1)	MXPA03011728A (fr)
NZ (1)	NZ530118A (fr)
PL (1)	PL367632A1 (fr)
RU (1)	RU2269516C2 (fr)
SK (1)	SK15372003A3 (fr)
WO (1)	WO2002102777A2 (fr)
ZA (1)	ZA200309557B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL158334A0 (en) *	2001-04-09	2004-05-12	Teva Pharma	Polymorphs of fexofenadine hydrochloride
US20040044038A1 (en)	2002-06-10	2004-03-04	Barnaba Krochmal	Polymorphic form XVI of fexofenadine hydrochloride
GB0319935D0 (en)	2003-08-26	2003-09-24	Cipla Ltd	Polymorphs
JP2007532687A (ja) *	2004-04-26	2007-11-15	テバファーマシューティカルインダストリーズリミティド	フェキソフェナジン塩酸塩の結晶形およびその製造方法
ITMI20041143A1 (it) *	2004-06-08	2004-09-08	Dipharma Spa	Polimorfi di fexofenadina e procedimento per la loro preparazione
ITMI20041568A1 (it) *	2004-07-30	2004-10-30	Dipharma Spa	"polimorfi di fexofenadina base"
JP2008514641A (ja) *	2004-09-28	2008-05-08	テバファーマシューティカルインダストリーズリミティド	結晶形フェキソフェナジン、およびその調製方法
WO2007007347A1 (fr) *	2005-07-07	2007-01-18	Wockhardt Limited	Procédé industriel de préparation du chlorhydrate de fexofénadine avec un minimum de produits secondaires
RU2283649C1 (ru) *	2005-10-27	2006-09-20	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Фармацевтическая композиция для лечения аллергических заболеваний
US20090306135A1 (en)	2008-03-24	2009-12-10	Mukesh Kumar Sharma	Stable amorphous fexofenadine hydrochloride
CN104072402B (zh) *	2014-07-16	2016-08-17	昆山龙灯瑞迪制药有限公司	一种新结晶形式的盐酸非索非那定化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4254129A (en) *	1979-04-10	1981-03-03	Richardson-Merrell Inc.	Piperidine derivatives
EP1688142A1 (fr) *	1992-08-03	2006-08-09	Sepracor Inc.	Le carboxylate de la terfénadine et le traitement de l'irritation de la peau
EP1178041A1 (fr) *	1994-05-18	2002-02-06	Aventis Pharmaceuticals Inc.	Procédés de préparation de formes anhydres et hydratées de derivés de piperidine antihistaminiques
US6153754A (en) *	1995-12-21	2000-11-28	Albany Molecular Research, Inc.	Process for production of piperidine derivatives
IN191492B (fr)	1999-05-25	2003-12-06	Ranbaxy Lab Ltd
GB0018691D0 (en) *	2000-07-28	2000-09-20	Rolabo Sl	Process

2001
- 2001-07-31 IL IL15926601A patent/IL159266A0/xx unknown
- 2001-07-31 JP JP2003505320A patent/JP2005507374A/ja active Pending
- 2001-07-31 AU AU2001278094A patent/AU2001278094B2/en not_active Ceased
- 2001-07-31 RU RU2004101045/04A patent/RU2269516C2/ru not_active IP Right Cessation
- 2001-07-31 NZ NZ530118A patent/NZ530118A/en unknown
- 2001-07-31 EE EEP200400010A patent/EE200400010A/xx unknown
- 2001-07-31 CA CA002450858A patent/CA2450858C/fr not_active Expired - Fee Related
- 2001-07-31 PL PL01367632A patent/PL367632A1/xx not_active Application Discontinuation
- 2001-07-31 BR BR0117054-6A patent/BR0117054A/pt not_active Application Discontinuation
- 2001-07-31 WO PCT/US2001/023994 patent/WO2002102777A2/fr not_active Ceased
- 2001-07-31 SK SK1537-2003A patent/SK15372003A3/sk unknown
- 2001-07-31 CA CA002646802A patent/CA2646802A1/fr not_active Abandoned
- 2001-07-31 MX MXPA03011728A patent/MXPA03011728A/es active IP Right Grant
- 2001-07-31 KR KR10-2003-7016163A patent/KR20040015734A/ko not_active Ceased
- 2001-07-31 CZ CZ20033358A patent/CZ20033358A3/cs unknown
- 2001-07-31 EP EP10010066A patent/EP2261209A1/fr not_active Withdrawn
- 2001-07-31 CN CNB018233791A patent/CN100390145C/zh not_active Expired - Fee Related
- 2001-07-31 EP EP01956057A patent/EP1399422A2/fr not_active Withdrawn
- 2001-07-31 HU HU0401546A patent/HUP0401546A2/hu unknown
2003
- 2003-12-09 ZA ZA200309557A patent/ZA200309557B/xx unknown
- 2003-12-09 IL IL159266A patent/IL159266A/en not_active IP Right Cessation
- 2003-12-11 BG BG108435A patent/BG108435A/xx unknown
- 2003-12-18 CO CO03110519A patent/CO5540340A2/es not_active Application Discontinuation
2007
- 2007-11-06 JP JP2007289084A patent/JP2008094848A/ja active Pending

Also Published As

Publication number	Publication date
HUP0401546A2 (hu)	2004-12-28
NZ530118A (en)	2007-05-31
CA2646802A1 (fr)	2002-12-27
WO2002102777A2 (fr)	2002-12-27
SK15372003A3 (sk)	2004-08-03
MXPA03011728A (es)	2004-07-08
CN1518540A (zh)	2004-08-04
BG108435A (en)	2004-12-30
PL367632A1 (en)	2005-03-07
WO2002102777A3 (fr)	2003-02-27
CA2450858C (fr)	2009-04-07
RU2269516C2 (ru)	2006-02-10
RU2004101045A (ru)	2005-06-27
IL159266A (en)	2010-11-30
EP1399422A2 (fr)	2004-03-24
JP2008094848A (ja)	2008-04-24
IL159266A0 (en)	2004-06-01
WO2002102777A8 (fr)	2003-10-30
BR0117054A (pt)	2004-07-27
CA2450858A1 (fr)	2002-12-27
KR20040015734A (ko)	2004-02-19
CN100390145C (zh)	2008-05-28
CZ20033358A3 (en)	2004-04-14
CO5540340A2 (es)	2005-07-29
EP2261209A1 (fr)	2010-12-15
AU2001278094B2 (en)	2006-01-12
ZA200309557B (en)	2004-09-14
JP2005507374A (ja)	2005-03-17

Similar Documents

Publication	Publication Date	Title
EE200400010A (et)	2004-02-16	4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid
LTC1463716I2 (lt)	2018-06-25	Pirolidino ir piperidino dariniai kaip NK1 antagonistai
NO20023319D0 (no)	2002-07-09	Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen
EE200300007A (et)	2004-08-16	Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid
EE05454B1 (et)	2011-08-15	1-[4-(5-tsanoindool-3-l)butl]-4-(2-karbamolbensofuraan-5-l)piperasiinvesinikkloriidi polmorfsed vormid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EA200700150A1 (ru)	2007-08-31	Новая фармацевтическая соль 1-бензил-4-[(5,6-диметокси-1-инданон)-2-ил] метилпиперидина (донепезил)
HUP0402019A3 (en)	2009-07-28	Piperidine derivatives useful as ccr5 antagonists and pharmaceutical compositions containing them
NO20023293D0 (no)	2002-07-08	Piperidin- og piperazinderivater som virker som 5-HT2A- reseptorantagonister
DE60203481D1 (de)	2005-05-04	Piperidinderivate als neurokinin 1 antagonisten
IL189986A0 (en)	2008-08-07	Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof
SI1505066T1 (sl)	2007-04-30	Polimorf 4-(2-(4-(1-(2-etoksietil)-1h-benzimidazol-2-il) -1-piperidinil)-alfa, alfa-dimetil-benzenocetne kisline
WO2001094313A3 (fr)	2002-04-04	Modification cristalline
AU2003245029A1 (en)	2004-11-04	Novel crystalline forms of donepezil hydrochloride
HUP0201673A3 (en)	2004-07-28	Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-alpha, alpha-dimethylbenzeneacetic acid
PL325264A1 (en)	1998-09-14	Novel derivatives of phenyl-alpha,alpha-dimethylacetic acid, method of obtaining such derivatives, method of obtaining a pharmaceutic agent, application of such derivatives and method of obtaining 4-{4-[4-(hydroxydiphenylmethyl)piperidin]-1-hydroxybutyl}-phenyl-alpha,alpha-dimethylacetic acid
EP1616861A3 (fr)	2006-02-08	Procédé de préparation de composés cétoniques
NZ306319A (en)	1999-08-30	1-alkylphenyl substituted 4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butanol derivatives and medicaments
UA72890C2 (en)	2005-05-16	A crystalline form of osanetant (variants), a method for the preparation thereof (variants) and a pharmaceutical composition
FI955916L (fi)	1995-12-08	N-((1-(4-(4-fluorifenoksi)butyyli)-4-piperidinyyli)-N-metyyliamino)-2-bentsotiatsololeja luokan III rytmihäiriölääkkeinä
IL152570A0 (en)	2003-05-29	A process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-alpha, alpha-di methylbenzeneacetic acid
WO2007049303A3 (fr)	2008-01-03	Procede ameliore pour preparer de la fexofenadine a purete elevee
IS7901A (is)	2005-06-20	4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
ATE554068T1 (de)	2012-05-15	Verfahren zur herstellung von ketoverbindungen
TH86760B (th)	2007-10-01	การรวมกันที่รักษาโรคได้ ซึ่งประกอบด้วยตัวบล็อกช่องแคลเซียมชนิดไดไฮโดรไพริดีนที่ออกฤทธิ์ระยะยาว และสเททิน
HUP0302910A3 (en)	2008-02-28	Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine